Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Viasys Enters Home Care Ventilation Arena Via Pulmonetic Systems Buy

This article was originally published in The Gray Sheet

Executive Summary

Viasys Healthcare's acquisition of LTV ventilator manufacturer Pulmonetic Systems will allow the firm to enter the estimated $80 mil. home care mechanical ventilator market

You may also be interested in...



Regulatory News In Brief

IVD symbol final guidance issued: FDA retains recommendation that accompanying glossaries for symbols be included as part of package inserts rather than as separate labeling. However, the 1Nov. 30 guidance on "Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use" withdraws a draft proposal to "exercise enforcement discretion if a company used the symbol that represents 'manufacturer' to satisfy...610.64," a section dealing with the name and address of distributors. "Upon reflection, that symbol does not appear applicable to section 610.64," FDA explains in an accompanying Federal Register notice. The device and biologics centers issued the draft version of the document in October 2003, after industry pressed for symbols in lieu of text to aid harmonization efforts and save space (2"The Gray Sheet" Nov. 3, 2003, p. 6)...

Biogen Sees Improving Momentum In Slow Leqembi Launch

Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel